M Duvic Selected Research

M Duvic Research Topics

Disease

18	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 10/2018 - 01/2000
8	Mycosis Fungoides 10/2018 - 11/2000
7	Neoplasms (Cancer) 05/2012 - 08/2000
4	Lymphoma (Lymphomas) 12/2015 - 11/2000
4	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2001 - 08/2000
3	Lymphadenopathy 08/2001 - 11/2000
2	Pruritus (Itching) 10/2018 - 10/2000
2	Necrosis 06/2010 - 12/2000
2	Alopecia Areata 06/2010 - 01/2001
2	Kaposi Sarcoma (Kaposi's Sarcoma) 12/2000 - 10/2000
2	Acquired Immunodeficiency Syndrome (AIDS) 12/2000 - 10/2000
1	Virus Diseases (Viral Diseases) 07/2009
1	Hypothyroidism 08/2006
1	Alopecia (Baldness) 07/2003
1	Bronchiolitis Obliterans Syndrome 03/2003
1	Melanoma (Melanoma, Malignant) 02/2003
1	T-Cell Lymphoma (Lymphoma, T Cell) 06/2002
1	Exfoliative Dermatitis (Erythroderma) 08/2001
1	Scleromyxedema (Lichen Myxedematosus) 08/2001
1	Atopic Dermatitis (Atopic Eczema) 08/2001
1	Pancreatitis 05/2001
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2001
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2001
1	Hypoalbuminemia 01/2001
1	Disease Progression 12/2000
1	Cryofibrinogenemia 12/2000
1	Infections 11/2000
1	Diphtheria 11/2000
1	Capillary Leak Syndrome 11/2000
1	Skin Diseases (Skin Disease) 10/2000
1	Opportunistic Infections (Opportunistic Infection) 10/2000
1	Folliculitis (Sycosis) 10/2000
1	Skin Neoplasms (Skin Cancer) 08/2000

Drug/Important Bio-Agent (IBA)

8	Bexarotene (LGD1069)FDA Link 01/2014 - 11/2000
4	CytokinesIBA 10/2018 - 10/2000
3	RetinoidsIBA 08/2006 - 08/2000
3	denileukin diftitox (Ontak)FDA Link 01/2001 - 11/2000
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2014 - 01/2001
2	Interleukin-12 (IL 12)IBA 06/2010 - 09/2001
2	AntigensIBA 07/2008 - 11/2000
2	Ficusin (Psoralen)IBA 08/2001 - 01/2001
2	LigandsIBA 01/2001 - 12/2000
1	Valacyclovir (Valtrex)FDA LinkGeneric 10/2018
1	Brentuximab VedotinIBA 01/2018
1	forodesineIBA 09/2014
1	Purine-Nucleoside PhosphorylaseIBA 09/2014
1	Liposomes (Liposome)IBA 01/2014
1	Gemcitabine FDA Link 05/2012
1	liposomal doxorubicin (Doxil)FDA Link 05/2012
1	Bortezomib (Velcade)FDA Link 05/2012
1	cyclo(Arg-Pro) (CI 4)IBA 07/2009
1	Oxidoreductases (Dehydrogenase)IBA 07/2009
1	SteroidsIBA 03/2003
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 02/2003
1	Mechlorethamine (Nitrogen Mustard)FDA Link 02/2003
1	Trimetrexate (JB11)FDA Link 06/2002
1	Methotrexate (Mexate)FDA LinkGeneric 06/2002
1	Fas Ligand Protein (Fas Ligand)IBA 09/2001
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2001
1	Isotretinoin (Accutane)FDA LinkGeneric 08/2001
1	Interferon-alpha (Interferon Alfa)IBA 08/2001
1	Immunosuppressive Agents (Immunosuppressants)IBA 08/2001
1	peldesineIBA 06/2001
1	Triglycerides (Triacylglycerol)IBA 05/2001
1	Retinoid X Receptors (Retinoid X Receptor)IBA 05/2001
1	Chemokine ReceptorsIBA 03/2001
1	ChemokinesIBA 03/2001
1	Transaminases (Aminotransferases)IBA 01/2001
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2001
1	Alitretinoin FDA Link 12/2000
1	CryoglobulinsIBA 12/2000
1	Proteins (Proteins, Gene)FDA Link 11/2000
1	Interleukin-2 (IL2)IBA 11/2000
1	SuperantigensIBA 11/2000
1	Interleukin-10 (Interleukin 10)IBA 10/2000
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2000
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2000
1	tazarotene (Tazorac)FDA Link 08/2000
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 08/2000
1	Messenger RNA (mRNA)IBA 08/2000

Therapy/Procedure

15	Therapeutics 04/2011 - 01/2000
3	Stem Cell Transplantation 12/2015 - 08/2001
2	Photopheresis 04/2011 - 03/2003
2	Radiotherapy 02/2003 - 01/2001
1	Withholding Treatment 08/2006
1	Skin Cream 06/2001
1	Transplantation 01/2001
1	Secondary Prevention 11/2000